Literature DB >> 10887303

The use of standardized extracts in allergen immunotherapy.

H S Nelson1.   

Abstract

BACKGROUND: Double-blind, placebo-controlled studies have established that injection allergen immunotherapy is clinically effective. However, it is not known to what extent the doses of allergen extract commonly used in clinical practice match those that have been used in these controlled studies.
OBJECTIVE: The aim of this study was to determine by questionnaire the doses of standardized allergen extracts commonly used by board-certified allergists in the United States and to compare these with doses that have proven effective in double-blind, placebo-controlled studies.
METHODS: A questionnaire containing a hypothetical case and asking for a recommended allergen prescription for maintenance immunotherapy was mailed to 500 randomly selected board-certified members of the American Academy of Allergy, Asthma and Immunology living in the United States. The recommended doses were compared with those doses of the extracts that had been proven effective by using major allergen content figures for representative standardized US allergen extracts provided by an allergy extract laboratory.
RESULTS: Responses were received from 118 (23%) of the addressees. Eighty (16%) contained interpretable data on maintenance dosing for extracts. The median doses of pollen recommended were comparable with those that have been demonstrated to be clinically effective. Median doses of house dust mites were only slightly lower than those that have proven effective. Median doses of animal dander, on the other hand, were well below those used effectively in controlled studies. Although the median doses used were often in the range of proven doses, the range of doses recommended by allergists included some that were one tenth to one five hundredth those of the median doses.
CONCLUSION: In the absence of useful guidance from the federal regulatory authorities, American allergists, for the most part, use doses of pollens and house dust mites that are within the proven range. Their dosing of animal dander is generally below proven effective doses. There is, however, a wide range of dosing of all extracts used, and there is use of mixes that have no botanical basis. Therefore there is need for studies defining what are effective and ineffective allergen extract doses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887303     DOI: 10.1067/mai.2000.107197

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Environmental assessment and exposure control of dust mites: a practice parameter.

Authors:  Jay Portnoy; Jeffrey D Miller; P Brock Williams; Ginger L Chew; J David Miller; Fares Zaitoun; Wanda Phipatanakul; Kevin Kennedy; Charles Barnes; Carl Grimes; Désirée Larenas-Linnemann; James Sublett; David Bernstein; Joann Blessing-Moore; David Khan; David Lang; Richard Nicklas; John Oppenheimer; Christopher Randolph; Diane Schuller; Sheldon Spector; Stephen A Tilles; Dana Wallace
Journal:  Ann Allergy Asthma Immunol       Date:  2013-12       Impact factor: 6.347

2.  Skin prick testing and immunotherapy in nasobronchial allergy: our experience.

Authors:  Amrith Lal; Sunaina Sunaina Waghray; N N Nand Kishore
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-02-08

3.  Immune response modulation by recombinant peptides expressed in virus-like particles.

Authors:  E V Svirshchevskaya; L Alekseeva; A Marchenko; N Viskova; T M Andronova; S V Benevolenskii; V P Kurup
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

4.  Update on allergy immunotherapy.

Authors:  William Davidson; Sean Lucas; Larry Borish
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

5.  Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice.

Authors:  Toshiharu Hayashi; Keiko Hasegawa; Yuji Sasaki
Journal:  Inflammation       Date:  2007-09-12       Impact factor: 4.092

6.  The efficacy of allergen immunotherapy with cat dander in reducing symptoms in clinical practice.

Authors:  Aerik A Williams; John R Cohn; Shirley M Fung; Patricia Padams
Journal:  Biomed Res Int       Date:  2013-07-31       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.